Affymax, Takeda update Hematide strategy

Affymax Inc. (NASDAQ:AFFY) gained $1.70 (26%) to $8.13 on Thursday after it and partner

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE